These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 16413844

  • 1. Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant.
    Gaffield ME, Curtis KM, Mohllajee AP, Peterson HB.
    Contraception; 2006 Feb; 73(2):134-44. PubMed ID: 16413844
    [Abstract] [Full Text] [Related]

  • 2. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [Abstract] [Full Text] [Related]

  • 3. Vaginal ring contraception.
    Kerns J, Darney P.
    Contraception; 2011 Feb; 83(2):107-15. PubMed ID: 21237335
    [Abstract] [Full Text] [Related]

  • 4. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
    Verhoeven CH, Dieben TO.
    Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
    [Abstract] [Full Text] [Related]

  • 5. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis.
    Vercellini P, Barbara G, Somigliana E, Bianchi S, Abbiati A, Fedele L.
    Fertil Steril; 2010 May 01; 93(7):2150-61. PubMed ID: 19328469
    [Abstract] [Full Text] [Related]

  • 6. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
    Massai R, Mäkäräinen L, Kuukankorpi A, Klipping C, Duijkers I, Dieben T.
    Hum Reprod; 2005 Oct 01; 20(10):2764-8. PubMed ID: 15980008
    [Abstract] [Full Text] [Related]

  • 7. [Vaginal contraception: new form of administration of hormonal contraception].
    Knuist M, Hamerlynck JV.
    Ned Tijdschr Geneeskd; 2003 Oct 25; 147(43):2095-7. PubMed ID: 14619196
    [Abstract] [Full Text] [Related]

  • 8. Comparing patient telephone callback rates for different hormonal birth control delivery systems.
    Victor I, Fink RA.
    Am J Ther; 2006 Oct 25; 13(6):507-12. PubMed ID: 17122531
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S, Miller MM, Mishell DR, Archer DF, Poindexter A, Schmidt J, Zampaglione E, Implanon US Study Group.
    Contraception; 2005 May 25; 71(5):319-26. PubMed ID: 15854630
    [Abstract] [Full Text] [Related]

  • 10. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
    Guazzelli CA, de Queiroz FT, Barbieri M, Torloni MR, de Araujo FF.
    Contraception; 2010 Sep 25; 82(3):256-9. PubMed ID: 20705154
    [Abstract] [Full Text] [Related]

  • 11. Factors associated with willingness to use the contraceptive vaginal ring.
    Gilliam M, Holmquist S, Berlin A.
    Contraception; 2007 Jul 25; 76(1):30-4. PubMed ID: 17586133
    [Abstract] [Full Text] [Related]

  • 12. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series.
    Calhoun A, Ford S, Pruitt A.
    Headache; 2012 Sep 25; 52(8):1246-53. PubMed ID: 22789073
    [Abstract] [Full Text] [Related]

  • 13. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.
    Roumen F.
    Eur J Contracept Reprod Health Care; 2002 Dec 25; 7 Suppl 2():19-24; discussion 37-9. PubMed ID: 12659398
    [Abstract] [Full Text] [Related]

  • 14. Incidence of vaginitis with the etonogestrel/ethinyl estradiol vaginal ring.
    Baker E.
    J Reprod Med; 2004 Aug 25; 49(8):699; author reply 699. PubMed ID: 15457864
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study.
    Fleischer K, van Vliet HA, Rosendaal FR, Rosing J, Tchaikovski S, Helmerhorst FM.
    Thromb Res; 2009 Aug 25; 123(3):429-35. PubMed ID: 18829069
    [Abstract] [Full Text] [Related]

  • 16. The transdermal patch and the vaginal ring: two novel methods of combined hormonal contraception.
    Swica Y.
    Obstet Gynecol Clin North Am; 2007 Mar 25; 34(1):31-42, viii. PubMed ID: 17472863
    [Abstract] [Full Text] [Related]

  • 17. Contraceptive patch and vaginal ring vs. combined oral contraceptives.
    Meyer S.
    Am Fam Physician; 2009 Aug 01; 80(3):232. PubMed ID: 19621832
    [No Abstract] [Full Text] [Related]

  • 18. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
    Jick SS, Jick H.
    Contraception; 2006 Oct 01; 74(4):290-2. PubMed ID: 16982227
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study.
    Lete I, Doval JL, Pérez-Campos E, Sánchez-Borrego R, Correa M, de la Viuda E, Gómez MA, González JV, Lertxundi R, Martínez MT, Mendoza N, Robledo J.
    Contraception; 2007 Aug 01; 76(2):77-83. PubMed ID: 17656174
    [Abstract] [Full Text] [Related]

  • 20. Neuropathy associated with etonogestrel implant insertion.
    Brown M, Britton J.
    Contraception; 2012 Nov 01; 86(5):591-3. PubMed ID: 22770789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.